newsfilter
← Latest News
GlobeNewswire·

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

-2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading gene-editing